Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Healthcare Editor
UK
+20 year(s) experience
Medtech Insight
How coronavirus affects IVDs businesses depends on the branch of the industry they are in, a German survey of manufacturers shows. German labs performed one million COVID-19 tests last week.
Topic Coronavirus EU Policy & Regulation
Medtech Insight
Coronavirus has diverted the focus of health systems away from early cancer detection, says a new report by Cancer Research UK, urging a rebalancing of priorities.
Topic Cancer Policy & Regulation
Medtech Insight
New MHRA guidance says the EU CE marking will continue to be used for devices and diagnostics in Great Britain until June 2023, and thereafter a standalone regulatory system will come into place.
Topic Medtech-Brexit Regulation
Medtech Insight
Although the EU MDR and IVDR will fall outside the scope of new post-Brexit medtech regulations for Great Britain in 2021, the UK MHRA says it has the chance of developing its own world-leading regulatory regime.
Topic Medtech-Brexit Regulation Brexit
Medtech Insight
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
Medtech Insight
Securing a favorable post-Brexit free trade agreement with the US is the principal aim of the UK’s Department for International Trade, and the UK medtech industry is pressing its case for closer business links with its largest non-EU trading partner.
Medtech Insight
Parliamentary committee meetings on the UK’s devices bill have been postponed as measures to tackle COVID-19 have been moved to center stage.
Medtech Insight
COVID-19 is of no lesser importance to the UK medtech industry, but attention is now refocusing on Brexit, future regulation and trade deals.
Topic EU Medtech-Brexit
Medtech Insight
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.
Topic EU Medtech-Brexit Regulation Brexit
Medtech Insight
The second round of the UK’s talks on exiting the EU by the end of the year have been called off over COVID-19, but whether this is a temporary derailment or a more structural issue for the UK’s planned EU separation is the question emerging.
Topic Brexit
In Vivo
As night turned to day on June 24, it became clearer by the hour that the unthinkable had happened, and the UK’s long and acrimonious debate about its 43-year membership of the European Union had ended in a victory for the Leave group. The local health care products industries made their views clear some weeks ago, but today and in the months to come, they will have to confront a Plan B that was never in the plans.
Topic Market Access Brexit
Medtech Insight
As promised in mid-April, and just a month away from the UK’s yes/no vote on continued membership of the EU, the UK ABHI has completed and released a survey of its members’ views on this theme – its second within the past year.
Topic Brexit
In Vivo
The use of virtual, real-time and at-home testing to provide clinical trials data has been steadily gaining the interest of the health care industry. COVID-19 has put this opportunity into sharper focus, says CNS trials technology developer Cambridge Cognition, which is now adding a voice option to its portfolio.
Topic Coronavirus Clinical Trials
Medtech Insight
Germany’s authorities are back on guard against COVID-19 following renewed regional outbreaks. Diagnostics manufacturers will continue to play a strong part in bringing the pandemic substantially under control, a recent industry association virtual conference heard.
Medtech Insight
Better health care infrastsructures, enhanced digital capabilities and temporary VAT cuts are part the German coalition government’s new investment plan to revive the economy in aftermath of COVID-19.
Medtech Insight
27 Oct 2020
Medtech Insight
19 Oct 2020
Medtech Insight
19 Oct 2020
Medtech Insight
16 Oct 2020
Medtech Insight
15 Oct 2020
Medtech Insight
14 Oct 2020
In Vivo
14 Oct 2020
Medtech Insight
12 Oct 2020
Medtech Insight
08 Oct 2020
Medtech Insight
28 Sep 2020
Medtech Insight
24 Sep 2020
In Vivo
23 Sep 2020
Medtech Insight
23 Sep 2020
Medtech Insight
22 Sep 2020
In Vivo
21 Sep 2020
